Core Capital Management & Research’s Abbott ABT Stock Holding History

Core Capital Management & Research’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.3K	Buy	+705	New	+$64.3K	0.04%	106

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Core Capital Management & Research's ABT Position: Q2 2026 in Review

Core Capital Management & Research opened a new position in Abbott (ABT) in Q2 2026: 705 shares worth $82.3K. The stake represents 0.04% of the portfolio and ranks #106 among its holdings.

2,980 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Core Capital Management & Research held 705 shares of Abbott worth $82.3K as of Q2 2026.
Abbott was a new Core Capital Management & Research position in Q2 2026.
Abbott made up 0.04% of Core Capital Management & Research's portfolio in Q2 2026, its #106 holding.
2,980 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Core Capital Management & Research's 13F filing for Q2 2026, filed 9 Sep 2026.